Literature DB >> 20621017

The role of microRNAs in colorectal cancer.

Mao Liu1, Huiping Chen.   

Abstract

MicroRNAs are small non-coding RNAs which regulate gene expression in a post-transcriptional manner. Although the first study was published about 15 years ago, knowledge about their role in regulation of cell proliferation, differentiation, apoptosis and immunity has been greatly advanced recently. Their association with formation, angiogenesis, metastasis and chemotherapy resistance of tumors has become one of the core issues in epigenetics of cancer. Here, we summarize the latest findings concerning microRNAs involved in different signal pathways leading to colorectal cancer, introduce some new potential microRNAs as biomarkers in diagnosis and prognosis, and analyze its application in the treatment of cancer. Copyright 2010 Institute of Genetics and Developmental Biology and the Genetics Society of China. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621017     DOI: 10.1016/S1673-8527(09)60053-9

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  25 in total

1.  MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.

Authors:  Andrew Feber; Liqiang Xi; Arjun Pennathur; William E Gooding; Santhoshi Bandla; Maoxin Wu; James D Luketich; Tony E Godfrey; Virginia R Litle
Journal:  Ann Thorac Surg       Date:  2011-03-21       Impact factor: 4.330

2.  MicroRNA polymorphisms and risk of colorectal cancer.

Authors:  Stephanie L Schmit; Jeremy Gollub; Michael H Shapero; Shu-Chen Huang; Hedy S Rennert; Andrea Finn; Gad Rennert; Stephen B Gruber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-23       Impact factor: 4.254

3.  Utility of micro-ribonucleic acid profile for predicting recurrence of rectal cancer.

Authors:  Alexander M Riordan; Marie K Thomas; Sean Ronnekleiv-Kelly; Thomas Warner; Peter G Geiger; Gregory D Kennedy
Journal:  J Surg Res       Date:  2012-03-13       Impact factor: 2.192

Review 4.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

5.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

6.  Differential miRNA expression in the mouse jejunum during garlic treatment of Eimeria papillata infections.

Authors:  Saleh Al-Quraishy; Denis Delic; Helmult Sies; Frank Wunderlich; Abdel Azeem S Abdel-Baki; Mohamed Abdel Monam Dkhil
Journal:  Parasitol Res       Date:  2011-02-08       Impact factor: 2.289

7.  Asymmetric exponential amplification reaction on a toehold/biotin featured template: an ultrasensitive and specific strategy for isothermal microRNAs analysis.

Authors:  Jun Chen; Xueqing Zhou; Yingjun Ma; Xiulian Lin; Zong Dai; Xiaoyong Zou
Journal:  Nucleic Acids Res       Date:  2016-06-02       Impact factor: 16.971

8.  Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.

Authors:  Fung Lin Yong; Chee Wei Law; Chee Woon Wang
Journal:  BMC Cancer       Date:  2013-06-08       Impact factor: 4.430

9.  Identification of serum microRNA profiles in colon cancer.

Authors:  E Hofsli; W Sjursen; W S Prestvik; J Johansen; M Rye; G Tranø; H H Wasmuth; I Hatlevoll; L Thommesen
Journal:  Br J Cancer       Date:  2013-04-04       Impact factor: 7.640

10.  Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation.

Authors:  Francesca Migheli; Andrea Stoccoro; Fabio Coppedè; Wan Adnan Wan Omar; Alessandra Failli; Rita Consolini; Massimo Seccia; Roberto Spisni; Paolo Miccoli; John C Mathers; Lucia Migliore
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.